Earnings call briefSecond-quarter 2026
Hims & Hers Health raises 2026 revenue outlook to $3.1 billion to $3.3 billion
It expects 2026 adjusted EBITDA of $275 million to $325 million, a 9% margin at the midpoints.
GetSignal Hims & Hers Health HIMS
Hims & Hers Health said on its second-quarter call that it has raised its 2026 revenue outlook to $3.1 billion to $3.3 billion, a year-over-year increase of 32% to 41%. It expects third-quarter revenue of $880 million to $900 million and adjusted EBITDA of $75 million to $95 million. It also expects international revenue of at least $600 million in 2026, operating at or near breakeven on adjusted EBITDA.
Quotes from the call
“We expect adjusted EBITDA to be between $75 million to $95 million, representing an adjusted EBITDA margin of 10% at the midpoint of both ranges.”
Key facts from the call
- 2026 revenue outlook
- $3.1 billion to $3.3 billion
- Third-quarter revenue outlook
- $880 million to $900 million
- 2026 adjusted EBITDA outlook
- $275 million to $325 million
- Third-quarter adjusted EBITDA outlook
- $75 million to $95 million
Source: Hims & Hers Health's second-quarter 2026 earnings call, August 10, 2026.
Written by GetSignal with AI from the company's earnings call.
Not investment advice.
More earnings call briefs
- Constellation Energy expects nuclear uprate costs of about $4.3 billion
CEG Constellation Energy Q3 2026 call
- Howard Hughes Holdings says its insurance ambition is a return on equity in excess of 20%
HHH Howard Hughes Holdings Q3 2026 call
- Brookfield Asset Management now sees 2026 earnings modestly below early view
BAM Brookfield Asset Management Q3 2026 call
- Enbridge says it expects 2026 results at the midpoint of its guidance range
ENB Enbridge Q3 2026 call
- TeraWulf sees about half of contracted IT capacity earning revenue by end of Q1
WULF TeraWulf Q3 2026 call
